|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/28 | |||
| A61P 35/00 | |||
| A61P 29/00 | |||
| A61K 39/00 | |||
| C07K 16/30 |
| (11) | Patento numeris | 3193929 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15763016.1 |
| Europos patento paraiškos padavimo data | 2015-09-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-07-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-06-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2015/071073 |
| Data | 2015-09-15 |
| (87) | Numeris | WO 2016/041947 |
| Data | 2016-03-24 |
| (30) | Numeris | Data | Šalis |
| 201462050948 P | 2014-09-16 | US | |
| 201462067642 P | 2014-10-23 | US | |
| 201462083929 P | 2014-11-25 | US | |
| 201462093141 P | 2014-12-17 | US | |
| 201462093124 P | 2014-12-17 | US |
| (72) |
ANDRE, Pascale, FR
BLERY, Mathieu, FR
PATUREL, Carine, FR
SOULAS, Caroline, FR
WAGTMANN, Nicola, FR
|
| (73) |
Innate Pharma,
117, Avenue de Luminy, 13009 Marseille,
FR
|
| (54) | TREATMENT REGIMENS USING ANTI-NKG2A ANTIBODIES |
| TREATMENT REGIMENS USING ANTI-NKG2A ANTIBODIES |